VEGF inhibition can modulate the tumor microenvironment by normalizing vasculature, reducing myeloid-derived suppressor cells and regulatory T-cells, and potentially enhancing T-cell infiltration and function, thereby synergizing with PD-1 blockade (7). This evidence concerns the gene VEGFA and neoplasm.